BioCardia, Inc. (BCDA) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $13 million, BioCardia, Inc. is a micro-cap company. The stock currently trades at $1.36, up 5.43% today, with a 52-week range of $1.00–$3.20.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | — | $-2.90 | -427.3% | |
| 2023 | — | $-0.55 | +17.9% | |
| 2022 | — | $-0.67 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-26 | 0001437749-25-009397 | SEC ↗ |
| 2023-12-31 | 2024-03-27 | 0001437749-24-009587 | SEC ↗ |
| 2022-12-31 | 2023-03-29 | 0001437749-23-008312 | SEC ↗ |
| 2021-12-31 | 2022-03-29 | 0001437749-22-007544 | SEC ↗ |
| 2020-12-31 | 2021-03-30 | 0001437749-21-007543 | SEC ↗ |
| 2019-12-31 | 2020-04-09 | 0001437749-20-007405 | SEC ↗ |
| 2018-12-31 | 2019-04-02 | 0001437749-19-006300 | SEC ↗ |
| 2017-12-31 | 2018-03-16 | 0001437749-18-004870 | SEC ↗ |
| 2016-12-31 | 2017-03-30 | 0001437749-17-005643 | SEC ↗ |
| 2015-12-31 | 2016-03-25 | 0001136261-16-000427 | SEC ↗ |
| 2014-12-31 | 2015-03-24 | 0001136261-15-000089 | SEC ↗ |
| 2013-12-31 | 2014-03-24 | 0001136261-14-000123 | SEC ↗ |
| 2012-12-31 | 2013-03-22 | 0001136261-13-000152 | SEC ↗ |
| 2011-12-31 | 2012-03-29 | 0001136261-12-000180 | SEC ↗ |
| 2010-12-31 | 2011-03-31 | 0001136261-11-000181 | SEC ↗ |
| 2009-12-31 | 2010-03-31 | 0001136261-10-000078 | SEC ↗ |
| 2008-12-31 | 2009-03-31 | 0001136261-09-000124 | SEC ↗ |
| 2008-06-30 | 2008-09-29 | 0000925741-08-000003 | SEC ↗ |